Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01768221 · ClinicalTrials.gov registry record · NA
Caregiver Outlook: An Evidence-based Intervention for the Chaplain Toolkit
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT01768221: Completed NA study, sponsored by Duke University.
NCT01768221 is a NA study that has completed, run by Duke University. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01768221, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This one-arm pilot study will evaluate the feasibility and acceptability of Caregiver Outlook, a manualized chaplain-led intervention to improve the well-being of caregivers of seriously ill patients. Study Activities and Population Group: The investigators anticipate enrolling 36 informal caregivers (adults) through DUMC providers and/or self-referral. Potential subjects will be screened for study eligibility, consented if eligible and interested, and one week later administered a baseline survey by phone. Next, the chaplain-led intervention will be delivered by phone in three one-hour sessions, spanning a one month window. After session 3, subjects will receive a check-in phone call to briefly discuss their any additional thoughts, questions or concerns they may have. Sessions will be audio recorded. After intervention completion, follow-up surveys will be administered by phone at two points in time. Data Analysis and Risk/Safety Issues: This is a mixed-methods study involving qualitative thematic analysis and survey data, collected from the adult caregiver subjects. There are no known physical risks to participation, and the study team will work to ensure confidentiality and data safety/integrity.
Primary Outcome
Assess caregivers' spiritual strengths and experiences by conducting surveys and interviews to measure change in anxiety, preparation and completion, grief, depression and caregiver reactions at baseline and post intervention at 6 weeks, and 8 weeks.
Interventions
- BEHAVIORAL Caregiver Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT01768221 record still lists
NCT01768221 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Caregiver Intervention is the first listed.
NCT01768221 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01768221 about?
NCT01768221 is a clinical study titled "Caregiver Outlook: An Evidence-based Intervention for the Chaplain Toolkit". This one-arm pilot study will evaluate the feasibility and acceptability of Caregiver Outlook, a manualized chaplain-led intervention to improve the well-being of caregivers of seriously ill patients. Study Activities and Population Group: The investigators anticipate enrolling 36 informal caregiv...
What is the current status of trial NCT01768221?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2012-01. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01768221?
The interventions under investigation include: Caregiver Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01768221?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01768221's enrollment target sits among peer trials
33 1574th of 2000 higher than 423 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia